These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17084571)

  • 1. [Critical evaluation and predictive value of clinical presentation in out-patients with acute community-acquired pneumonia].
    Mayaud C; Fartoukh M; Prigent H; Parrot A; Cadranel J
    Med Mal Infect; 2006; 36(11-12):625-35. PubMed ID: 17084571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of community-acquired pneumonia by trained family general practitioners.
    Potena A; Simoni M; Cellini M; Cartabellotta A; Ballerin L; Piattella M; Putinati S
    Int J Tuberc Lung Dis; 2008 Jan; 12(1):19-25. PubMed ID: 18173872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe Q fever community-acquired pneumonia (CAP) mimicking Legionnaires' disease: Clinical significance of cold agglutinins, anti-smooth muscle antibodies and thrombocytosis.
    Cunha BA; Nausheen S; Busch L
    Heart Lung; 2009; 38(4):354-62. PubMed ID: 19577708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycoplasma pneumonia in young children, 2-5 years of age.
    Bunnag T; Lochindarat S; Srisan P; Jetanachai P
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S124-7. PubMed ID: 19253507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global and local epidemiology of community-acquired pneumonia: the experience of the CAPNETZ Network.
    Welte T; Köhnlein T
    Semin Respir Crit Care Med; 2009 Apr; 30(2):127-35. PubMed ID: 19296412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-terminal provasopressin (copeptin) in patients with community-acquired pneumonia--influence of antibiotic pre-treatment: results from the German competence network CAPNETZ.
    Krüger S; Ewig S; Kunde J; Hanschmann A; Marre R; Suttorp N; Welte T;
    J Antimicrob Chemother; 2009 Jul; 64(1):159-62. PubMed ID: 19403654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of the Infectious Diseases Society of America/American Thoracic Society criteria to predict severe community-acquired pneumonia caused by Streptococcus pneumoniae.
    Kontou P; Kuti JL; Nicolau DP
    Am J Emerg Med; 2009 Oct; 27(8):968-74. PubMed ID: 19857416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving outcomes in elderly patients with community-acquired pneumonia by adhering to national guidelines: Community-Acquired Pneumonia Organization International cohort study results.
    Arnold FW; LaJoie AS; Brock GN; Peyrani P; Rello J; Menéndez R; Lopardo G; Torres A; Rossi P; Ramirez JA;
    Arch Intern Med; 2009 Sep; 169(16):1515-24. PubMed ID: 19752410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myocardial infarction in hospitalized patients with community-acquired pneumonia.
    Ramirez J; Aliberti S; Mirsaeidi M; Peyrani P; Filardo G; Amir A; Moffett B; Gordon J; Blasi F; Bordon J
    Clin Infect Dis; 2008 Jul; 47(2):182-7. PubMed ID: 18533841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying barriers to the rapid administration of appropriate antibiotics in community-acquired pneumonia.
    Barlow G; Nathwani D; Myers E; Sullivan F; Stevens N; Duffy R; Davey P
    J Antimicrob Chemother; 2008 Feb; 61(2):442-51. PubMed ID: 18065412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment failure rates and health care utilization and costs among patients with community-acquired pneumonia treated with levofloxacin or macrolides in an outpatient setting: a retrospective claims database analysis.
    Ye X; Sikirica V; Schein JR; Grant R; Zarotsky V; Doshi D; Benson CJ; Riedel AA
    Clin Ther; 2008 Feb; 30(2):358-71. PubMed ID: 18343274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Community-acquired pneumonia in older patients: does age influence systemic cytokine levels in community-acquired pneumonia?
    Kelly E; MacRedmond RE; Cullen G; Greene CM; McElvaney NG; O'Neill SJ
    Respirology; 2009 Mar; 14(2):210-6. PubMed ID: 19272082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe community-acquired pneumonia: validation of the Infectious Diseases Society of America/American Thoracic Society guidelines to predict an intensive care unit admission.
    Liapikou A; Ferrer M; Polverino E; Balasso V; Esperatti M; Piñer R; Mensa J; Luque N; Ewig S; Menendez R; Niederman MS; Torres A
    Clin Infect Dis; 2009 Feb; 48(4):377-85. PubMed ID: 19140759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the economic impact of a half-day reduction in length of hospital stay among patients with community-acquired pneumonia in the US.
    Raut M; Schein J; Mody S; Grant R; Benson C; Olson W
    Curr Med Res Opin; 2009 Sep; 25(9):2151-7. PubMed ID: 19601711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiological studies on pulmonary pathogens in HIV-positive and -negative subjects with or without community-acquired pneumonia with special emphasis on Mycoplasma pneumoniae.
    Shankar EM; Kumarasamy N; Vignesh R; Balakrishnan P; Solomon SS; Murugavel KG; Saravanan S; Velu V; Farooq SM; Hayath K; Muthu S; Solomon S; Rao UA
    Jpn J Infect Dis; 2007 Nov; 60(6):337-41. PubMed ID: 18032830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Community-acquired pneumonia with atypical (mycoplasmic and chlamydial) infection].
    Trubnikov GV; Poliakova IG; Butakova LIu
    Ter Arkh; 2009; 81(1):16-20. PubMed ID: 19253703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Costs of treating lower respiratory tract infections.
    Monte SV; Paolini NM; Slazak EM; Schentag JJ; Paladino JA
    Am J Manag Care; 2008 Apr; 14(4):190-6. PubMed ID: 18402511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and outcome of community-acquired pneumonia due to Gram-negative bacilli.
    Falguera M; Carratalà J; Ruiz-Gonzalez A; Garcia-Vidal C; Gazquez I; Dorca J; Gudiol F; Porcel JM
    Respirology; 2009 Jan; 14(1):105-11. PubMed ID: 18699803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel targets in the management of pneumonia.
    Díaz LA; Mortensen EM; Anzueto A; Restrepo MI
    Ther Adv Respir Dis; 2008 Dec; 2(6):387-400. PubMed ID: 19124384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.